The Lancet· Peter Holger Johnsen, Frederik Emil Juul, Dag Arne Lihaug Hoff, Eline Randulff Hillestad, Øyvind Holme, Linn Kallbekken Skjevling, Hege Marie Hansen, Marthe H Rasmus, Lauren Barnett, Sarah J E Barry, Erik Hjerde, Kenneth Lindstedt, Dorota J Buczek, Jan G Hatlebakk, Elisabeth K Steinsvik, Birgitte Berentsen, Kjetil Kjeldstad Garborg, Jørgen Valeur, Per Christian Valle, Magnus Løberg, Mette Kalager, Michael Bretthauer, Rasmus Goll·· 7 天前精选评分47
[Articles] 粪便微生物群移植治疗肠易激综合征 (REFIT2)：一项随机、双盲、安慰剂对照的 3 期临床试验
[Articles] Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial
导读
REFIT2 3 期试验显示，粪便微生物群移植未能为肠易激综合征患者带来临床获益。这项随机、双盲、安慰剂对照研究结果表明，单独调节微生物群可能不足以改善 IBS 症状。
来源：The Lancet · thelancet.com